Every day, your questions and answers from the editorial staff on the news and its treatment on franceinfo radio.
Published on 02/12/2024 15:23
Reading time: 3min
Since this morning, Monday, December 2, taxi drivers and medical vehicles have been carrying out snail-like operations and blockades throughout France, while a draft new agreement with Health Insurance provides for a reduction in transport costs for the patients. This convention is expected to come into force in January 2025.”Normal that they defend their livelihood, but it is the sick who are the first victimsdeplores Corinne. “My mother's doctor in Ephad continues to prescribe her travel vouchers that she can no longer use. So she pays for her taxis out of her own pocket.“.
It is Antoine Deiana from franceinfo who answers him and specifies the rules which determine the reimbursement and support of these vehicles. “To benefit from an approved taxi, with no advance fees, you must meet a certain number of conditions. The list is long and is available on Ameli.fr“. If the drivers are mobilizing, it is therefore above all because it is the amount that the taxis receive on these journeys which is concerned by this draft agreement. If the drivers are “paid at around €1.50 per kilometer for medical transport, with the new agreement, the rate would increase to €1 per kilometer“However, the discussions are not over, assures Thomas Fatôme, general director of the National Health Insurance Fund, guest of franceinfo: “This is a significant expense for Health Insurance, almost 3 billion euros, so it is normal to have discussions, but these discussions are not fixed.“.
Sébastien de Lyon, for his part, wonders about the Telethon, the 38th edition of which, opened Friday November 27, 2024, ended on the night of Saturday to Sunday December 1, raising nearly 80 million euros for the benefit of research into rare genetic diseases: “French research seems very efficient in carrying out promising clinical trials, but industrialization seems more laborious. For what ?” “Absolutely truereplies Serge Braun, scientific director of the AFM-Téléthon, the closer you get to the drug, the greater the financial stakes“Clinical trials take time and several validations must be confirmed, assures the director. However, the Telethon is absolutely necessary. Serge Braun mentions in particular the case of infantile spinal muscular atrophy, “a rare disease, for which there are currently three drugs. Two were directly supported by the Telethon, including a gene therapy product. And they save lives“.
To ask a question in franceinfo and you, you can use this form to leave a voice or written message.
France